Uravi Defence & (URAVIDEF)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At first glance, Uravi Defence looks like a fallen growth story—down from ₹509 to ₹145 in a year. But in investing, a falling price is only interesting if the underlying business is worth more. Here, the numbers fail Graham's basic tests. The company earned just 4.51% on equity in the latest year, and ROCE is zero. That means the business is not generating real returns on the capital it employs. Sales grew 8.54%, but profits fell 77.14%; the latest quarter's net profit is essentially zero. This is a classic case of a company spending money to grow but failing to earn a decent rupee of profit. With a P/E around 80.75 and a PEG of 9.46, the market is still pricing in heroic future growth. But where is that growth? Not in the bottom line. Book value is ₹33.24, so paying ₹145.20 means 4.37 times net assets for a deteriorating earner. There is no dividend yield—shareholders aren't even being paid to wait. On the positive side, debt is not excessive—D/E at 0.45—and promoter holding is 54.19%, so interest alignment exists. But promoter ownership does not create a moat. The Piotroski F-score of 3/9 screams weak balance-sheet fundamentals and poor operating efficiency. A Graham disciple would demand a margin of safety; this stock offers almost none. It might be a turnaround candidate if management can fix margins and capital allocation, but I do not bank on turnarounds with zero return on capital. For an Indian retail investor, patience is better: wait for proof in profit numbers, or wait for a lower price. Value is not a falling stock; it's a growing stream of earnings at a reasonable price. Here, the earnings stream has broken.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer